Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

scientific article

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00002371-200501000-00007
P932PMC publication ID2175172
P698PubMed publication ID15614045
P5875ResearchGate publication ID8116431

P50authorSteven RosenbergQ2347448
P2093author name stringPaul F Robbins
Mark E Dudley
Juhua Zhou
P2860cites workgas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formationQ24313245
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesQ24676216
Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitorsQ24676265
Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte traffickingQ28186076
Association of the growth-arrest-specific protein Gas7 with F-actin induces reorganization of microfilaments and promotes membrane outgrowthQ28215766
Construction of human liver cancer vascular endothelium cDNA expression library and screening of the endothelium-associated antigen genesQ30831587
Identification of tumor antigens and T-cell epitopes, and its clinical applicationQ31033906
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productQ33202641
Human tumor antigens for cancer vaccine developmentQ33776127
A listing of human tumor antigens recognized by T cellsQ33943569
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsQ34415738
Progress in the development of immunotherapy for the treatment of patients with cancerQ34570245
Ligands for L-selectin: homing, inflammation, and beyondQ35698423
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytesQ36365851
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patientsQ36551911
A Novel CRM1-mediated Nuclear Export Signal Governs Nuclear Accumulation of Glyceraldehyde-3-phosphate Dehydrogenase following Genotoxic StressQ40616428
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patientsQ40671907
Human tumor antigens recognized by T cellsQ41196996
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.Q44794043
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.Q54765828
Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte TraffickingQ56603390
High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognitionQ62056655
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary reportQ68100559
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2Q72052802
MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in miceQ73086909
Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanomaQ73475194
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaQ74535384
P433issue1
P921main subjectpatientQ181600
P304page(s)53-62
P577publication date2005-01-01
P1433published inJournal of ImmunotherapyQ15763946
P1476titlePersistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
P478volume28